Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Zentalis Pharmaceuticals Inc shares valued at $29,373 were purchased by Myers Scott Dunseth on Apr 30 ’25. At $1.40 per share, Myers Scott Dunseth acquired 21,000 shares. The insider’s holdings grew to 281,192 shares worth approximately $0.4 million following the completion of this transaction.
Also, Bruns Ingmar purchased 20,000 shares, netting a total of over 45,656 in proceeds. Following the buying of shares at $2.28 each, the insider now holds 36,629 shares.
Before that, Cam Gallagher had added 687 shares to its account. In a trade valued at $1,374, the Former Director bought Zentalis Pharmaceuticals Inc shares for $2.00 each.
As published in a research note from Wedbush on August 12, 2024, Zentalis Pharmaceuticals Inc [ZNTL] has been rated up from an Underperform to a Neutral and the price target has been revised to $4. Analysts at UBS downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid June. As of June 18, 2024, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for ZNTL. Earlier on June 18, 2024, Wedbush downgraded its rating. Their new recommendation was “an Underperform” for ZNTL stock which previously was a “a Neutral”.
Analyzing ZNTL Stock Performance
During the last five days, there has been a drop of approximately -5.33%. Over the course of the year, Zentalis Pharmaceuticals Inc shares have dropped approximately -53.14%. Shares of the company reached a 52-week high of $3.3300 on 01/03/25 and a 52-week low of $1.0100 on 04/09/25. A 50-day SMA is recorded $1.6793, while a 200-day SMA reached $2.8200.
Support And Resistance Levels for Zentalis Pharmaceuticals Inc (ZNTL)
According to the 24-hour chart, there is a support level at 1.3500, which, if violated, would cause prices to drop to 1.2800. In the upper region, resistance lies at 1.4650. The next price resistance is at 1.5100. RSI (Relative Strength Index) is 47.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0548, which suggests the price will decrease in the coming days. Percent R is at 28.16%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
